Table 1. Potential biomarkers between TBEV patients and the healthy control group.
| Lipid | p-value | Log2 (FC) | VIP | Trend |
|---|---|---|---|---|
| PC 36:5|PC 16:0_20:5 | 1.44E-14 | 10.54 | 6.43 | ↑ |
| PC 28:3;1 | 4.33E-17 | 1.89 | 2.18 | ↑ |
| PC 36:2;1 | 1.44E-12 | 8.07 | 5.03 | ↑ |
| PC 38:3;2 | 1.60E-11 | 1.21 | 1.53 | ↑ |
| PC 38:7 | 9.07E-15 | 9.67 | 6.48 | ↑ |
| CE 18:3;1 | 4.4266E-19 | 3.65 | 3.15 | ↑ |
| LPE O-16:1 | 2.88E-09 | 1.24 | 1.57 | ↑ |
| TAG 60:10|TAG 18:0_20:4_22:6 | 0.001 | −1.08 | 1.01 | ↓ |
| PE O-37:5|PE O-17:1_20:4 | ||||
| TAG 60:11 TAG 16:0_22:5_22:6 | 2.46E-05 | −1.10 | 1.03 | ↓ |
| DAG 40:8|DAG 18:2_22:6 | 1.09E-05 | −1.06 | 1.25 | ↓ |
| PC 30:1 | 5.44E-05 | 1.02 | 1.27 | ↑ |
| PC 38:3;2 | 3.02E-06 | 1.04 | 1.18 | ↑ |
| PC 28:3;1 | 4.23E-13 | 2.04 | 2.15 | ↑ |
| PC 36:5|PC 16:0_20:5 | 8.23E-39 | 10.54 | 6.51 | ↑ |
| PC 38:7 | 4.84E-41 | 9.83 | 6.41 | ↑ |
| CE 18:3;1 | 6.94E-18 | 3.68 | 2.93 | ↑ |
| TAG 42:0|TAG 10:0_16:0_16:0 | 0.012673 | 1.20 | 1.17 | ↑ |
| TAG 52:6 | 0.001648 | −1.03 | 1.12 | ↓ |
| LPE O-16:1 | 5.01E-9 | 1.34 | 1.63 | ↑ |
| PC 36:2;1 | 3.02E-06 | 7.92 | 4.77 | ↑ |
| TAG 54:7(18:2/18:2/18:3) | 0.001 | −1.17 | 1.13 | ↓ |
| TAG 54:8|TAG 18:2_18:3_18:3 | 0.005 | −1.66 | 1.44 | ↓ |
| TAG 58:10(18:2/18:2/22:6) | 0.0001 | −1.04 | 1.14 | ↓ |
| TAG 59:7 | 0.0001 | −1.22 | 1.37 | ↓ |
| DAG 40:8|DAG 18:2_22:6 | 6.56E-05 | −1.08 | 1.20 | ↓ |